Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Neuro-Degenerative Diseases|August 7, 2010
TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10hIshrut Hussain, David C Harrison, Julie Hawkins, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2004
Alpha-synuclein and Parkinson's diseaseAlessandra Recchia, Patrizia Debetto, Alessandro Negro, et al.Glia|August 4, 2005
Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivationClaudia Rosin, Sergio Colombo, Andrew A Calver, et al.Frontiers in Pharmacology|July 19, 2021
Co-Ultramicronized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte Precursor Cell Differentiation is Associated With Tyro3 Receptor UpregulationLaura Facci, Massimo Barbierato, Mariella Fusco, et al.Journal of Neuroinflammation|June 22, 2019
A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitisGabriella Contarini, Davide Franceschini, Laura Facci, et al.Frontiers in Human Neuroscience|August 9, 2024
Unilateral tactile agnosia as an onset symptom of corticobasal syndromeLaura Facci, Stefania Basilico, Manuela Sellitto, et al.CNS & Neurological Disorders Drug Targets|July 12, 2014
A novel prion protein-tyrosine hydroxylase interactionMattia Vicario, Adriana Zagari, Vincenzo Granata, et al.Neurobiology of Disease|March 4, 2008
Generation of a alpha-synuclein-based rat model of Parkinson's diseaseAlessandra Recchia, David Rota, Patrizia Debetto, et al.CNS & Neurological Disorders Drug Targets|September 6, 2016
Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for NeuroprotectionHari Shanker Sharma, Dafin F Muresanu, José V Lafuente, et al.Pain and Therapy|March 30, 2018
A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A ReviewGiustino Varrassi, Mariella Fusco, Stephen D Skaper, et al.Pageof 11